scispace - formally typeset
R

Richard A. Flavell

Researcher at Yale University

Publications -  1389
Citations -  223064

Richard A. Flavell is an academic researcher from Yale University. The author has contributed to research in topics: Immune system & T cell. The author has an hindex of 231, co-authored 1328 publications receiving 205119 citations. Previous affiliations of Richard A. Flavell include National Institute for Medical Research & University of Michigan.

Papers
More filters
Journal ArticleDOI

Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice

TL;DR: It is found that islets from these transgenic mice are immunogenic for naive T cells in vitro and in vivo, and mice expressing the costimulator B7-1 specifically on beta cells do not develop diabetes, suggesting that expression of the B 7-1 costimulators is not sufficient to abrogate the tolerance to peripheral antigens.
Journal ArticleDOI

Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo

TL;DR: RAG2/−γc−/− TPO-humanized mice represent a useful model to study human hematopoiesis in vivo and maintenance of human stem and progenitor cells was improved, as demonstrated by serial transplantation.
Journal ArticleDOI

Inflammasome activation in infected macrophages drives COVID-19 pathology

TL;DR: In this article , the authors showed that SARS-CoV-2 infection and replication in lung resident human macrophages is a critical driver of lung pathology, as inhibition of the NLRP3 inflammasome pathway reversed chronic lung pathology.
Journal ArticleDOI

Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity.

TL;DR: An anti-human SIRPα antibody, KWAR23, is developed, which in combination with tumor-opsonizing antibodies, greatly augmented neutrophil and macrophage antitumor activity in vitro and in vivo and may represent a promising candidate for combination therapies.